Workflow
J&J(JNJ)
icon
Search documents
Johnson & Johnson's Options Frenzy: What You Need to Know - Johnson & Johnson (NYSE:JNJ)
Benzinga· 2025-10-03 15:02
Investors with a lot of money to spend have taken a bearish stance on Johnson & Johnson (NYSE:JNJ).And retail traders should know.We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with JNJ, it often means somebody knows something is about to happen.So how do we know what these investors just did? Today, Benzinga's options scanner sp ...
道指涨幅扩大至1%,再创新高
Ge Long Hui A P P· 2025-10-03 15:01
格隆汇10月3日|道指涨幅扩大至1%,再创历史新高。成分股中,强生涨近2%亦创历史新高。 ...
道指涨幅扩大至1%,再创历史新高
Mei Ri Jing Ji Xin Wen· 2025-10-03 14:55
Core Viewpoint - The Dow Jones Industrial Average (DJIA) has increased by 1%, reaching a new historical high on October 3rd, indicating strong market performance and investor confidence [1]. Company Performance - Johnson & Johnson's stock rose nearly 2%, achieving a new all-time high [1]. - UnitedHealth Group's stock increased by over 3%, reflecting positive market sentiment towards the company [1].
强生公司股价创下历史新高,最新上涨1.8%
Mei Ri Jing Ji Xin Wen· 2025-10-03 14:41
(文章来源:每日经济新闻) 每经AI快讯,10月3日,强生公司股价创下历史新高,最新上涨1.8%。 ...
Apple downgraded, Alibaba upgraded: Wall Street's top analyst calls
Yahoo Finance· 2025-10-03 13:42
Upgrades - Rothschild & Co Redburn upgraded Coinbase (COIN) to Buy from Neutral with a price target of $417, increased from $325, expecting retail volume growth to mitigate take rate compression [2] - Wells Fargo upgraded Johnson & Johnson (JNJ) to Overweight from Equal Weight with a price target of $212, up from $170, indicating that concerns around pharmaceutical tariffs and pricing risks are largely resolved [3] - Gordon Haskett upgraded Zillow (Z) to Buy from Hold with a price target of $90, citing favorable risk/reward due to negative sentiment affecting shares [3] - Fox Advisors upgraded Instacart (CART) to Outperform from Equal-Weight, believing the 24% decline in stock price since August 11 is "oversold" due to overblown competitive concerns [3] - Erste Group upgraded Alibaba (BABA) to Buy from Hold, noting the company's strong development in artificial intelligence applications [4] Downgrades - Jefferies downgraded Apple (AAPL) to Underperform from Hold with a price target of $205.16, down from $205.82, citing excessive expectations on the replacement cycle and prospects of the iPhone 18 Fold [5] - Piper Sandler downgraded Instacart (CART) to Neutral from Overweight with a price target of $41, down from $62, due to rising competitive pressures from major players like Amazon and Walmart [5] - Wolfe Research downgraded PayPal (PYPL) to Peer Perform from Outperform, with a fair value range of $70-$80, indicating shares may be range-bound until further proof of execution is shown [5] - KeyBanc downgraded Corteva (CTVA) to Sector Weight from Overweight without a price target, following the company's announcement to separate into two public companies [5] - Goldman Sachs downgraded Bumble (BMBL) to Neutral from Buy with a price target of $7, down from $8, stating that the stock's risk/reward is more balanced at current levels [5]
2 Dividend Stocks That Jim Cramer Wants Every Retiree to Own
247Wallst· 2025-10-03 13:11
Core Insights - Retirees and older individuals represent a significant demographic that engages with Jim Cramer's Mad Money show [1] Group 1 - The show attracts a large audience from the retiree and older age groups, indicating a strong interest in financial advice among these demographics [1]
Jim Cramer's top 10 things to watch in the stock market Friday
CNBC· 2025-10-03 12:39
Group 1 - Boeing's new 777X widebody jet commercial debut is delayed to early 2027, potentially leading to significant non-cash accounting charges due to prolonged safety certification work [1] - BlackRock's Global Infrastructure Partners is negotiating to acquire Aligned Data Centers for approximately $40 billion, following a nearly $38 billion takeover of AES [1] - Johnson & Johnson was upgraded to buy from hold at Wells Fargo, with analysts optimistic about its cancer franchise and the removal of existential risks related to tariffs and drug pricing [1] Group 2 - Constellation Brands' price target was reduced to $175 from $205 by UBS, although the stock maintains a buy rating, trading at over 11 times forward earnings with a 2.9% dividend yield [1] - UBS maintains a sell rating on Tesla despite better-than-expected third-quarter deliveries, citing concerns over demand pull-forward due to EV tax credit expiration [1] - AeroVironment received price target increases to $400 and $415 from Citizens JMP and BTIG, both maintaining buy ratings and expressing strong bullish sentiment [1] Group 3 - KeyBanc downgraded Corteva to hold from buy following its announcement to split into two companies, raising concerns about the impact of breakups on stock performance [1] - Citi analysts proposed a three-way merger involving CSX, Canadian Pacific Kansas City, and Berkshire Hathaway-owned BNSF as a strategic response to the Union Pacific and Norfolk Southern merger [1] - Barclays lowered its price target on PepsiCo to $140 from $144, expressing caution ahead of earnings, particularly regarding sales and margins [1]
Government Shutdown Halts Jobs Data Release, J.P. Morgan Lifts Tesla Target
Stock Market News· 2025-10-03 12:38
Key TakeawaysThe U.S. Bureau of Labor Statistics has delayed the release of the critical September Nonfarm Payrolls report due to the ongoing government shutdown, leaving markets without a key economic indicator.J.P. Morgan has significantly raised its price target for electric vehicle giant Tesla (TSLA) to $150.00 from $115.00.Wells Fargo has issued a "buy" rating for Johnson & Johnson (JNJ), driven by continued improvements in the company's drug sales.Political leaders continue to grapple with the shutdow ...
Barclays Maintains a Hold Rating on Johnson & Johnson (JNJ) With a $176 PT
Insider Monkey· 2025-10-03 10:27
Core Insights - Artificial intelligence (AI) is identified as the greatest investment opportunity of the current era, with a strong emphasis on the urgency to invest in AI technologies now [1][13] - The energy demands of AI technologies are highlighted, with data centers consuming as much energy as small cities, leading to concerns about power grid strain and rising electricity prices [2][3] Investment Opportunity - A specific company is presented as a key player in the AI energy sector, owning critical energy infrastructure assets that are essential for supporting the anticipated surge in energy demand from AI data centers [3][7] - This company is characterized as a "toll booth" operator in the AI energy boom, benefiting from the increasing need for energy as AI technologies expand [4][5] Market Position - The company is noted for its unique position in the market, being debt-free and holding a significant cash reserve that is nearly one-third of its market capitalization [8] - It also has a substantial equity stake in another AI-related company, providing investors with indirect exposure to multiple growth engines in the AI sector [9][10] Strategic Advantages - The company is involved in large-scale engineering, procurement, and construction (EPC) projects across various energy sectors, including nuclear energy, which is crucial for America's future power strategy [7][8] - The current political climate, particularly Trump's tariffs and the push for onshoring, positions this company favorably to capitalize on domestic manufacturing and energy needs [5][14] Future Outlook - The influx of talent into the AI sector is expected to drive rapid advancements and innovation, reinforcing the importance of investing in AI-related companies [12] - The potential for significant returns is emphasized, with projections suggesting a possible 100% return within 12 to 24 months for investors who act now [15][19]
Johnson & Johnson (JNJ) Is Leading The Industry In Cancer Treatments, Says Jim Cramer
Yahoo Finance· 2025-10-02 07:08
We recently published 5 Stocks That Were On Jim Cramer’s Radar As He Discussed AI. Johnson & Johnson (NYSE:JNJ) is one of the stocks Jim Cramer recently discussed. Johnson & Johnson (NYSE:JNJ) is one of the most diversified healthcare companies in the world. The firm operates in the pharmaceutical, medical devices, and other industries. Cramer previously discussed the stock on September 11th, when he wondered whether the major “litigation overhang” surrounding the firm actually involved an “overplayed” ha ...